4.6 Article

Small Molecule Fisetin Modulates Alpha-Synuclein Aggregation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Alpha-Synuclein Inclusion Formation in Human Oligodendrocytes

Ye-Seul Yoon et al.

Summary: The research established a human oligodendrocyte model for the study of GCI formation, showing that mature human oligodendrocytes can uptake neuron-derived alpha-synuclein and develop GCI-like inclusions. This model might contribute to a better understanding of the pathogenesis of Multiple System Atrophy (MSA).

BIOMOLECULES & THERAPEUTICS (2021)

Review Cell Biology

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies

Ines C. Bras et al.

Summary: Accumulation of misfolded alpha-synuclein (aSyn) in the brain is central to Parkinson's disease (PD) pathogenesis, with cell-to-cell transmission leading to the stereotypical distribution and evolution of pathology forming synucleinopathies. While progress has been made, mechanisms involved in the transfer of aSyn assemblies and their role in driving PD progression remain unclear.
Article Biochemistry & Molecular Biology

Bioprospection of Natural Sources of Polyphenols with Therapeutic Potential for Redox-Related Diseases

Regina Menezes et al.

ANTIOXIDANTS (2020)

Review Clinical Neurology

Human tyrosine hydroxylase in Parkinson's disease and in related disorders

Toshiharu Nagatsu et al.

JOURNAL OF NEURAL TRANSMISSION (2019)

Review Pharmacology & Pharmacy

Exploring the Benefits of Cellular Models to Uncover Bioactive Polyphenols for Neurodegeneration

Rita Rosado-Ramos et al.

CURRENT PHARMACEUTICAL DESIGN (2018)

Article Multidisciplinary Sciences

(Poly)phenol-digested metabolites modulate alpha-synuclein toxicity by regulating proteostasis

Diana Macedo et al.

SCIENTIFIC REPORTS (2018)

Review Geriatrics & Gerontology

Exploring the power of yeast to model aging and age-related neurodegenerative disorders

Ana V. Oliveira et al.

BIOGERONTOLOGY (2017)

Review Biochemistry & Molecular Biology

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

Yvette C. Wong et al.

NATURE MEDICINE (2017)

Review Biochemistry & Molecular Biology

Protective effects of fisetin and other berry flavonoids in Parkinson's disease

Pamela Maher

FOOD & FUNCTION (2017)

Review Neurosciences

Polyphenols Beyond Barriers: A Glimpse into the Brain

Ines Figueira et al.

CURRENT NEUROPHARMACOLOGY (2017)

Article Biochemistry & Molecular Biology

Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity

Sandra Tenreiro et al.

HUMAN MOLECULAR GENETICS (2016)

Article Food Science & Technology

Flavonoids as dopaminergic neuromodulators

Manuela Meireles et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2016)

Article Neurosciences

Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?

Susana Almeida et al.

NEUROTOXICITY RESEARCH (2016)

Article Biochemistry & Molecular Biology

Cell and brain tissue imaging of the flavonoid fisetin using label-free two-photon microscopy

Tatiana B. Krasieva et al.

NEUROCHEMISTRY INTERNATIONAL (2015)

Article Biochemistry & Molecular Biology

(Poly)phenols protect from α-synuclein toxicity by reducing oxidative stress and promoting autophagy

Diana Macedo et al.

HUMAN MOLECULAR GENETICS (2015)

Review Cell Biology

From the baker to the bedside: yeast models of Parkinson's disease

Regina Menezes et al.

MICROBIAL CELL (2015)

Article Pharmacology & Pharmacy

3,3′,4′,5′-Tetrahydroxyflavone Induces Formation of Large Aggregates of Amyloid β Protein

Hiroko Ushikubo et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)

Article Clinical Neurology

Habitual intake of dietary flavonoids and risk of Parkinson disease

X. Gao et al.

NEUROLOGY (2012)

Article Neurosciences

The Neuroprotective Effect of Fisetin in the MPTP Model of Parkinson's Disease

Mital Y. Patel et al.

JOURNAL OF PARKINSONS DISEASE (2012)

Review Biochemistry & Molecular Biology

Tyrosine hydroxylase and regulation of dopamine synthesis

S. Colette Daubner et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)

Article Pharmacology & Pharmacy

Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite

Yasmine S. Touil et al.

BIOCHEMICAL PHARMACOLOGY (2011)

Article Biochemistry & Molecular Biology

Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line

Diana Scholz et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Article Clinical Neurology

Neuroinflammation in Parkinson's disease

Etienne C. Hirsch et al.

PARKINSONISM & RELATED DISORDERS (2011)

Article Multidisciplinary Sciences

EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity

Jan Bieschke et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Nutrition & Dietetics

Polyphenols and Human Health: Prevention of Disease and Mechanisms of Action

David Vauzour et al.

NUTRIENTS (2010)

Article Pharmacology & Pharmacy

Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells

Stefan Schildknecht et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)

Article Multidisciplinary Sciences

The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis

Aaron D. Gitler et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Neurosciences

Regulation of the norepinephrine transporter by α-synuclein-mediated interactions with microtubules

Alexis M. Jeannotte et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2007)

Article Multidisciplinary Sciences

Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory

Pamela Maher et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Biochemistry & Molecular Biology

Small molecule inhibitors of α-synuclein filament assembly

Masami Masuda et al.

BIOCHEMISTRY (2006)

Article Biochemistry & Molecular Biology

A yeast-based model of α-synucleinopathy identifies compounds with therapeutic potential

G Griffioen et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)

Review Clinical Neurology

Epidemiology of Parkinson's disease

Lonneke M. L. de Lau et al.

LANCET NEUROLOGY (2006)

Review Clinical Neurology

Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration

A Storch et al.

JOURNAL OF NEURAL TRANSMISSION (2004)

Review Nutrition & Dietetics

Polyphenols:: food sources and bioavailability

C Manach et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2004)

Article Multidisciplinary Sciences

Yeast cells provide insight into alpha-synuclein biology and pathobiology

TF Outeiro et al.

SCIENCE (2003)

Article Neurosciences

Attenuation of dopamine transporter activity by α-synuclein

C Wersinger et al.

NEUROSCIENCE LETTERS (2003)

Article Neurosciences

A role for α-synuclein in the regulation of dopamine biosynthesis

RG Perez et al.

JOURNAL OF NEUROSCIENCE (2002)

Article Biochemistry & Molecular Biology

Formation and removal of α-synuclein aggregates in cells exposed to mitochondrial inhibitors

HJ Lee et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)